Clinical Trials Browser

Terminated × Has results × Advanced Nonhematological Neoplasms × Clear all

NCT03370302 2023-02-08

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies

Phase 1 Terminated

28 enrolled 33 charts

Advanced Nonhematological Neoplasms